RT Book, Section A1 Jobst, Erin E. A1 Panus, Peter C. A1 Kruidering-Hall, Marieke SR Print(0) ID 1192813514 T1 Drugs Affecting the Cholinergic System T2 Pharmacology for the Physical Therapist, 2e YR 2020 FD 2020 PB McGraw-Hill Education PP New York, NY SN 9781259862229 LK accessphysiotherapy.mhmedical.com/content.aspx?aid=1192813514 RD 2024/03/28 AB CASE STUDYT. J. is a 25-year-old male who was involved in a motorcycle accident 4 weeks ago and transferred to an inpatient rehabilitation facility yesterday. He is scheduled for transfer training in the open gym immediately after breakfast today. As a result of the accident, T. J. has a stable spinal cord injury (SCI) at the T10 neurological level. The patient has no cardiovascular dysfunction. He is currently taking drugs to reduce spasticity, including tolterodine to reduce neurogenic detrusor overactivity (spastic bladder). The therapist and patient begin with a sliding board transfer from the wheelchair to the plinth. The patient urinates involuntarily during his initial attempt with the sliding board activities. The patient is embarrassed and states that this happened before when he attempted to sit up and reposition himself with his hands. The patient requests that this morning’s rehabilitation session be terminated. In the afternoon, T.J. does not want to come to the gym because he is concerned that the same problem will occur.